|
GLOBAL ADVISORY BOARD
 Ambassador John Palmer was former US
Ambassador Extraordinary and Plenipotentiary to Portugal and is
currently the Chairman of Gulf South Capital, Inc. Ambassador Palmer
served as Chairman of SkyTel from 1989 until its sale in 1999.
President George Bush appointed Ambassador Palmer to sit on the
President's Export Council, and President Ronald Reagan appointed him
as advisor to the Office of the US Trade Representative.
 Mr. Alfred Ford is
a Director of the Ford Motor Company Fund and the Josephine Ford Cancer
Center at Henry Ford Hospital in Detroit, Michigan. He serves on the
advisory board of ChannelNet. Continuing the legacy of his great
grandfather Henry Ford, Mr. Ford along with his wife, Dr. Sharmila
Bhattacharya, PhD, are visionary entrepreneurs and philanthropists with
deep strategic interests in improving global health, particularly in
the developing world. Mr. Ford is Chairman of the Board of Himalayan
Ski Village Private Limited, a $500 Million project developing an
eco-friendly ski resort in the Himalayas in India.
GLOBAL HEALTH & INDIA OPERATIONS
 Mr. Vinay Singhal was
formerly the Country Wide Director of the William J. Clinton
Foundation. Before that, he was CEO of Fortis Healthcare, India’s
second largest private sector hospital company. Under his leadership,
Fortis Healthcare rapidly established itself as a major force in
India’s growing medical industry. He has over 35 years of
experience in senior management positions with multi-national
corporations such as DCM, Hindustan Unilever, JK, Indo Rama and
Ranbaxy, and has had bottom-line responsibilities as CEO and President
of several major firms over the last fifteen years. Mr. Singhal has a
degree in Mechanical Engineering from the Birla Institute of Technology
& Science in Pilani, India and is a graduate of the Advanced
Management Program (AMP) at Harvard Business School.
TECHNOLOGY & PRODUCT DEVELOPMENT
 Dr. William A. Haseltine
PhD is the President of the Haseltine Foundation for Medical Sciences and the
Arts, a foundation that supports access to high quality health for the poor and
middle class of developing countries, primarily India. He is also the Chairman
of Haseltine Global Health, LLC, a company dedicated to creating new and more
efficient means to develop life saving drugs and medical devices. He was a
professor at Harvard Medical where he chaired two academic departments and is
also an Adjunct Professor at The Scripps Institute for Medical Research. He is well known for his pioneering work on
cancer and HIV/AIDS. From 1993-2004 he was the Chairman and CEO of Human Genome
Sciences Inc, a company that was first to discover a complete set of human genes and to create
genomic based medicines. He has founded eight biotechnology companies and
serves as an advisor to CMEA, a venture capital company. He is Co-Chair of the
President’s Council of the Cold Spring Harbor Laboratory, a member of the CEO
Council of the New York Academy of Science, Chairman of the Board of the UC
Berkeley Center of Synthetic Biology, a member of the Executive Committee of
the Brookings Institution, and a member of both the Council on Foreign
Relations and the Trilateral Commission, and a member of the Chairman’s Circle
of the Asia Society. Haseltine earned
his Ph.D. in biophysics from Harvard
University.
 Dr. Anantha Krishnan, ScD is the Director of Research & Development for Meso-, Micro- and
Nano-Technology at Lawrence Livermore National Laboratory (LLNL), where
he manages several projects involving MEMS, Bio-MEMS, Microfluidics and
Lab-on-a-Chip technologies that support National Bio-Defense programs.
From 1999 to 2005, Dr. Krishnan was a Program Manager at DARPA, where
he spearheaded several cutting-edge programs in microfluidics/MEMS chip
development as well as other areas of nanobiotechnology for the Defense
Sciences Office. From 1989- 1999, Dr. Krishnan held various positions,
including Vice President for Advanced Technology, at Computational
Fluid Dynamics Research Corporation, Inc. In 2005, he received the
Bronze Medal (highest civilian award in the United States from the DOD for Science
& Technology) from the Office of the Secretary of Defense in
recognition of his exceptional contributions at DARPA, and in 1996 he
received NASA’s New Technology/Innovation Award. Dr. Krishnan
obtained his doctoral degree in Mechanical Engineering from
Massachusetts Institute of Technology.
 Dr. Debra Peattie, PhD, MBA was
founding scientist at Vertex Pharmaceuticals, where she directed all
molecular biology research operations and developed their corporate
strategies. Founding member of the asset management division at MPM
Capital, she helped raise their initial $230 million BioVentures I
private equity fund. She has sourced multiple investment opportunities,
led due diligence teams and managed term sheet negotiations for a
variety of early stage therapeutic and platform technology companies.
She has also served as President of RCT BioVentures NE and Chief
Technology Officer of Valeo Medical. Dr. Peattie was a professor at the
Harvard School of Public Health under the MacArthur Foundation Program
and obtained a PhD in molecular biology under Nobel Laureate Walter
Gilbert from Harvard University and her MBA from Harvard Business
School.
|
